Cymbalta is marketed by Eli Lilly and Company.
Cymbalta is a serotonin and norepinephrine reuptake inhibitor indicated for the treatment of major depressive disorder, generalised anxiety disorder, diabetic peripheral neuropathic pain, and fibromyalgia.
Impax Laboratories is a technology-based specialty pharmaceutical company applying its formulation expertise and drug delivery technology to the development of controlled-release and specialty generics in addition to the development of branded products.